Funding Details
- Date Award
- September 30, 2023
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Premoney Valuation
-
$5,000,000
- Valuation
-
$15,000,000
Company Info
- Founding Year
- 2018
- Traction
- Cellens Inc. has secured partnerships with leading research institutions and pharmaceutical companies, demonstrating the value of their single-cell analysis platform. The company is poised for rapid growth as it continues to expand its customer base and advance its technology.
- Organizations Involved
- SOSV, Y Combinator, Stanford University, Genentech
- Founders
- Emily Chen, Michael Lee
- Company Description
- Cellens Inc. is a biotechnology company specializing in developing novel cell analysis technologies for the healthcare industry. Their proprietary platform enables high-throughput single-cell analysis, offering unprecedented insights into cellular behavior and interactions. Cellens' technology has applications in drug discovery, precision medicine, and basic research, empowering researchers and clinicians with advanced tools to study complex biological systems at the single-cell level.
- Market
- Biotechnology
- Location
-
San Francisco,
CA,
US
- Coinvestors
- SOSV, Y Combinator
Links